GLP-1 (T) Tirzepatide 20mg
$200.00
- Free US shipping over $150
- HPLC-tested at 99%+ purity
- US-based fulfillment
Used in Weight Loss Protocol.
Overview
Description
A GLP-1–based peptide researched for extended appetite regulation and metabolic control. Often chosen to reduce hunger between meals and support consistent eating patterns throughout the day.
This option is commonly selected by individuals who struggle with late-day cravings or overeating, supporting satiety signaling and more stable day-to-day energy in research settings.
Scientific Overview
GLP-1 analogs are studied for their role in appetite signaling and glucose metabolism pathways. Research explores mechanisms including enhanced glucose-dependent insulin signaling, reduced glucagon signaling, slowed gastric emptying, and central satiety regulation. These combined effects make GLP-1 pathways a major focus in weight-management and metabolic research models.
Product Details
- Compound: GLP-1 (T)
- Vial Size: 20mg
- Purity: ≥99%
- Form: Lyophilized powder
This product is intended strictly for laboratory research purposes only. It is not approved for human or veterinary use by the FDA or any other regulatory agency. Store in a cool, dry environment prior to reconstitution and handle using appropriate laboratory and aseptic techniques.
Frequently asked questions
Yes. Every batch of GLP-1 (T) Tirzepatide 20mg undergoes independent third-party testing using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). The Certificate of Analysis is published and accessible from the product page.
GLP-1 (T) Tirzepatide 20mg sold by MHS Longevity is verified to 99%+ purity, with the result documented in each batch's Certificate of Analysis. Anything below that threshold is rejected before release.
The Certificate of Analysis for GLP-1 (T) Tirzepatide 20mg is available directly from the product page and on our Third-Party Test Results page. Each COA includes the batch identifier, test date, testing method, and verified purity percentage.
GLP-1 (T) Tirzepatide 20mg ships from our US-based facility with standard or expedited options. Orders over $150 qualify for free standard US shipping. All orders are packaged discreetly with documented handling protocols.
No. GLP-1 (T) Tirzepatide 20mg is supplied strictly for laboratory research purposes only. It is not approved by the FDA for human or veterinary use, and it is not intended to diagnose, treat, cure, or prevent any disease.
MHS Longevity is a veteran-owned operation focused on pharmaceutical-grade research compounds. We source from vetted manufacturers, batch-test independently with HPLC and Mass Spectrometry, and publish every Certificate of Analysis. Pricing is transparent and the testing process is documented end-to-end.
Tirzepatide has a molecular weight of approximately 4813.5 g/mol. The empirical formula and exact monoisotopic mass are documented on each batch's Certificate of Analysis alongside the Mass Spectrometry result confirming the lipid modification was correctly incorporated.
Tirzepatide binds and activates both the GLP-1 receptor and the GIP receptor — two distinct incretin-system receptors that are normally agonized by separate endogenous hormones. Single-agonist GLP-1 analogues like semaglutide engage only the GLP-1 receptor. The dual-receptor pharmacology is the central feature of tirzepatide's design and the focus of much of the comparative research literature.
Tirzepatide is sent to an independent third-party laboratory for HPLC and Mass Spectrometry analysis before each batch is released. The lab's identifier and test date are published on the Certificate of Analysis for that batch.
FDA-approved pharmaceutical preparations of tirzepatide are formulated solutions produced under pharmaceutical-manufacturing standards and distributed through prescription channels for human therapeutic use. Research-grade Tirzepatide is a lyophilized peptide supplied for laboratory study only — it is not formulated, not pharmaceutical-grade, and not approved for human use. The molecule itself is the same active species; the regulatory status, formulation, and intended use are entirely different.
You may also like
Research & buying
The evidence behind GLP-1 (T) Tirzepatide 20mg and the questions to ask any vendor before you order.
Research details — GLP-1 (T) Tirzepatide 20mg
Tirzepatide is a synthetic peptide that acts as a co-agonist at two receptors — the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. It is the first "twincretin" molecule to reach widespread research circulation, and the published preclinical and clinical literature compares its dual-receptor pharmacology to single-agonist GLP-1 analogues. The form supplied here is for laboratory research only — it is not the same product as any FDA-approved pharmaceutical preparation, and nothing in this guide constitutes guidance for human use.
What is Tirzepatide?
Tirzepatide is a 39-amino-acid linear peptide developed at Eli Lilly's research laboratories. Its sequence is based on the GIP backbone with modifications drawn from the GLP-1 family, plus a 20-carbon fatty-diacid side chain attached via a γ-Glu / AEEA-AEEA spacer at a specific lysine residue. The combined architecture gives it dual-receptor agonism and an extended half-life relative to native incretin peptides. It is supplied as a lyophilized off-white powder for laboratory reconstitution.
Research context
Published research on tirzepatide centers on the pharmacology of simultaneous GLP-1 and GIP receptor agonism. Preclinical work has examined beta-cell function, glucose-disposal kinetics, and central-nervous-system effects on energy balance; clinical-trial literature describes specific pharmaceutical formulations administered under regulatory oversight. The twin-incretin design contrasts with single-agonist GLP-1 analogues like semaglutide, and head-to-head comparisons appear in the recent literature.
How Tirzepatide quality is verified
Tirzepatide is one of the more structurally complex peptides in research circulation: 39 amino acids with non-standard residues at multiple positions, a long fatty-diacid modification, and a multi-component spacer architecture. High-quality analytical verification is essential. Every batch of MHS Longevity Tirzepatide is submitted to an independent third-party laboratory before release:
- HPLC separates components and measures the tirzepatide peak as a percentage of total peak area. Anything below 99% is rejected.
- Mass Spectrometry confirms that the 20-carbon diacid side chain and AEEA-AEEA-γ-Glu spacer were correctly incorporated. Mass shifts associated with the lipid modification are documented for each batch — this is the verification step that catches missing or partial modification, which HPLC alone may not fully resolve.
What a Tirzepatide Certificate of Analysis shows
- Compound name and structural designation. Tirzepatide, with full sequence notation including the lipid modification and spacer architecture.
- Batch identifier. The unique ID linking certificate to vial.
- Test date. When the analysis was performed.
- Method. HPLC, MS, or both, with column and mobile-phase notes.
- Verified purity %. The HPLC result. We require 99%+.
- Lab and signatures. The independent lab performing the analysis.
Storage and handling (research lab context)
Lyophilized Tirzepatide should be stored at -20°C or below for extended stability. Once reconstituted in bacteriostatic water, the solution is typically held at 2–8°C and used within the documented stability window. The lipid-modified architecture is sensitive to extreme pH and repeated thermal cycling. Single-use aliquoting is good practice for any modified incretin peptide. Standard aseptic technique applies during reconstitution.
Where to buy GLP-1 (T) Tirzepatide 20mg
The same eight questions apply whether you're buying GLP-1 (T) Tirzepatide 20mgfrom us or anywhere else. Vendors who can't answer any of them are worth a closer look.
Vendor evaluation checklist
1. Is the Certificate of Analysis public and downloadable?
A vendor unwilling to publish HPLC/MS results for the batch you're buying has nothing to verify their purity claim against.
2. Which testing method was used — HPLC, Mass Spectrometry, or both?
HPLC measures purity. Mass Spectrometry confirms the molecule's identity. Reputable batches go through both.
3. What's the verified purity percentage on the published COA?
Industry research standard is 99%+. Below that, you're paying for a compound diluted with synthesis byproducts.
4. Where does the product ship from?
US-based fulfillment generally means shorter handling times, customs-free delivery, and clearer return remedies.
5. Is the price published at a single list rate, or hidden behind tier locks?
Opaque pricing is a yellow flag. Transparent vendors quote the same number to every customer.
6. What's the free-shipping threshold, if any?
Compare the all-in cost (product + shipping + handling) — not just the headline price.
7. How is the product stored prior to shipment?
Lyophilized peptides degrade with temperature swings. Vendors should disclose temperature-controlled storage.
8. Is there a documented damage-claim and return policy?
Discreet shipping carries handling risk. A clear, written policy protects you when something goes wrong.
MHS LongevityThis site - Price
- $200
- Purity
- 99%+
- Testing
- HPLC + MS
- COA public
- US-based
- Free shipping
- $150+
- Last checked
- May 13, 2026
| Vendor | Price | Listed purity | Testing method | COA public | US-based | Free shipping | Last checked |
|---|---|---|---|---|---|---|---|
MHS LongevityThis site | $200 | 99%+ | HPLC + MS | $150+ | May 13, 2026 |
Competitor data sourced from each vendor's public product page on the date shown. Listed purity reflects each vendor's own published claim; Certificate of Analysis availability is verified at the URL above. Data may have changed since last check.